the substrate bore no b-hydrogen. Interestingly, high chelation
control of the three contiguous stereogenic centers in product 9 was
accomplished. Thus, the stereochemistry between the methylallyl
side chain and the ring carbon was threo, and that between the
two ring carbons was erythro. The reaction proceeded through a
bicyclic chelation transition state (VII) to give threo g-crotylation
adduct. The erythro selectivity on the oxazolidinone ring could
be explained in terms of steric repulsion between the allylic and
benzoyl group in VIII.
In conclusion, a one-pot synthesis of nitrogen heterocyclic
compounds was initiated by the allylation of dicarbonyls 1.
Regio- and diastereoselective carbon–carbon bond formation was
established on the side chains of the rings.
This research was supported by a Japan Science and Technology
Agency Potentiality Verification Stage Project, a Grant-in-Aid
for Scientific Research from the Ministry of Education, Science,
Sports, and Culture Japan, The Mizuho-Espec Foundation, The
Kurata Memorial-Hitachi Science and Technology Foundation
and The Naito Foundation.
7426; (d) J. A. Marshall, Chem. Rev., 1996, 96, 31–48; (e) E. J. Thomas,
in Stereoselective Synthesis, Vol. 3, ed.: G. Helmchen, R. W. Hoffmann,
J. Mulzer and E. Schaumann, Georg Thieme, Stuttgart, 1996, Chapter
1.3.3.3.6, pp 1508-1540; (f) Y. Yamamoto, Acc. Chem. Res., 1987, 20,
243–249.
6 E. W. Abel, D. A. Armitage and D. B. Brady, Trans. Faraday Soc., 1966,
62, 3459–3462.
7 Synthetic uses of organotin compounds for example, see: (a) A. Baba,
I. Shibata and M. Yasuda, in Comprehensive Organometallic Chemistry
III, Vol. 9, Chapter 8, ed. R. H. Crabtree, D. Michael and P. Mingos,
Elsevier, Oxford, 2006, pp. 341–380; (b) M. Pereyre, P. J. Quintard and
A. Rahm, in Tin in Organic Synthesis, Butterworth, London, 1987;
(c) A. G. Davies, in Organotin Chemistry, VCH, Weinhelm, 1997.
8 We have already reported regiocontrolled synthesis of allylated 2-
oxazolidinones from b-acyl unsaturated aldehydes: I. Shibata, H. Kato,
N. Kanazawa, M. Yasuda and A. Baba, J. Am. Chem. Soc., 2004, 126,
466–467.
9 The formation of 4-methylene-2-oxazolidinones from treatment of
a-hydroxyketone with isocyanate: (a) B. M. Santoyo, C. Gonza´lez-
Romero, O. Merino, R. Mart´ınez-Palou, A. Fuentes-Benites, H. A.
Jime´nez-Va´zquez, F. Delgado and J. Tamariz, Eur. J. Org. Chem., 2009,
2505–2518; (b) C. Gonzalez-Romero, P. Bernal, F. Jimenez, M. Carmen
Cruz, A. Fuentes-Benites, A. Benavides, R. Bautista and J. Tamariz,
Pure Appl. Chem., 2007, 79, 181–191.
10 K. Yano, A. Baba and H. Matsuda, Bull. Chem. Soc. Jpn., 1992, 65,
66–70.
Notes and references
11 A Sn–O bond is easily added to heterocumulenes: (a) A. J. Bloodworth,
A. G. Davies and S. C. Vasishtha, J. Chem. Soc. C, 1967, 1309–1313;
(b) P. G. Harrison and J. J. Zuckerman, Inorg. Chem., 1970, 9, 175–181;
(c) D. P. Agur, G. Srivastaka and R. C. Mehrostra, Ind. J. Chem., 1974,
12, 1193; (d) S. Sakai, M. Miura, N. Wada and T. Fujinami, Bull. Chem.
Soc. Jpn., 1983, 56, 1873–1874; (e) H. Yasuda, J.-C. Choi, S.-C. Lee and
T. Sakakura, J. Organomet. Chem., 2002, 659, 133–141.
12 Synthesis of oxazolidinones from teminally-halogenated stannylcar-
bamate: (a) A. Baba, H. Kishiki, I. Shibata and H. Matsuda,
Organometallics, 1985, 4, 1329–1333; (b) I. Shibata, K. Nakamura,
A. Baba and Matsuda, Bull. Chem. Soc. Jpn., 1989, 62, 853–859.
13 (a) A. Gambaro, D. Marton and G. Tagliavini, J. Organomet. Chem.,
1981, 210, 57–61; (b) A. Boaretto, D. Marton and G. Tagliavini,
J. Organomet. Chem., 1987, 321, 199–207; (c) H. Miyake and K.
Yamamura, Chem. Lett., 1992, 1369–1372.
14 (Z)-Preference for crotylation was discussed: (a) V. J. Jephcote and E. J.
Thomas, Tetrahedron Lett., 1985, 26, 5327–5330; (b) A. Gambaro, P.
Gains, D. Marton, V. Peruzzo and G. Tagliavini, J. Organomet. Chem.,
1982, 231, 307–314.
15 D. Hoppe, in Stereoselective Synthesis, Vol. 3, Chapter 1.3.3, ed.:
G. Helmchen, R. W. Hoffmann, J. Mulzer and E. Schaumann, Georg
Thieme, Stuttgart, 1996, pp 1357–1368.
‡ The structures of 5d, 6d and 7–9 were confirmed by crystal structure
determinations.
1 (a) M. E. Dyen and D. Swern, Chem. Rev., 1967, 67, 197–246; (b) S.
Ozaki, Chem. Rev., 1972, 72, 457–456; (c) M. Raimond, C. Bertolotti,
E. Orlandini, C. Oro, G. Sartori and M. Selva, Tetrahedron Lett., 2007,
48, 2131–2134.
2 (a) G. Cardillo, M. Orena, S. Sandri and C. Tomashini, Tetrahedron,
1987, 43, 2505–2512; (b) A. V. Rama Rao, T. G. Murali Dhar, T. K.
Chakraborty and M. K. Gurjar, Tetrahedron Lett., 1988, 29, 2069–
2072; antibacterial drugs; (c) M. R. Barbachn, D. K. Hutchinson, S. J.
Brickner and G. E. Zurenko, J. Med. Chem., 1996, 39, 680–685.
3 R. T. Lewis, A. M. Macleod, K. J. Merchant, F. Kelleher, I. Sanderson,
R. H. Herbert, M. A. Cascieri, S. Sadowski, R. G. Ball and K.
Hoogsteen, J. Med. Chem., 1995, 38, 923–933.
4 B. M. Kim, J. P. Guare, C. M. Hanifin, D. J. Arford-Bickerstaff, J. P.
Vacca and R. G. Ball, Tetrahedron Lett., 1994, 35, 5153–5156.
5 (a) Y. Yamamoto and N. Asao, Chem. Rev., 1993, 93, 2207–2293;
(b) W. R. Roush, in Comprehensive Organic Synthesis, Vol. 2, ed.:
B. M. Trost and I. Fleming, Pergamon Press, Oxford, 1991, Chapter 1.1,
pp 1; (c) Y. Nishigaichi and A. Takuwa, Tetrahedron, 1993, 49, 7395–
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 2009–2011 | 2011
©